129 related articles for article (PubMed ID: 8670784)
1. Effect of transforming growth factor-beta on plasminogen activator production of cultured human uveal melanoma cells.
Park SS; Li L; Korn TS; Mitra MM; Niederkorn JY
Curr Eye Res; 1996 Jul; 15(7):755-63. PubMed ID: 8670784
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
3. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts.
Graham CH
Placenta; 1997; 18(2-3):137-43. PubMed ID: 9089774
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator is released into cultured medium by cultured human uveal melanocytes.
Wang Y; Hu DN; McCormick SA; Savage HE; O'Rourke J
Pigment Cell Res; 2002 Oct; 15(5):373-8. PubMed ID: 12213094
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells.
Meissauer A; Kramer MD; Hofmann M; Erkell LJ; Jacob E; Schirrmacher V; Brunner G
Exp Cell Res; 1991 Feb; 192(2):453-9. PubMed ID: 1899072
[TBL] [Abstract][Full Text] [Related]
6. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
Fawthrop FW; Oyajobi BO; Bunning RA; Russell RG
J Bone Miner Res; 1992 Dec; 7(12):1363-71. PubMed ID: 1481722
[TBL] [Abstract][Full Text] [Related]
7. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
[TBL] [Abstract][Full Text] [Related]
8. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
[TBL] [Abstract][Full Text] [Related]
11. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinoic acid on plasminogen activator expression in human melanoma cells.
Alexander CL; Edward M; MacKie RM
Melanoma Res; 1999 Aug; 9(4):360-7. PubMed ID: 10504054
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.
Teti A; De Giorgi A; Spinella MT; Migliaccio S; Canipari R; Onetti Muda A; Faraggiana T
Int J Cancer; 1997 Sep; 72(6):1013-20. PubMed ID: 9378535
[TBL] [Abstract][Full Text] [Related]
15. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
17. Urokinase-type-plasminogen-activator (uPA) production by human breast (myo) fibroblasts in vitro: influence of transforming growth factor-beta(1) (TGF beta(1)) compared with factor(s) released by human epithelial-carcinoma cells.
Sieuwerts AM; Klijn JG; Henzen-Logmand SC; Bouwman I; Van Roozendaal KE; Peters HA; Setyono-Han B; Foekens JA
Int J Cancer; 1998 Jun; 76(6):829-35. PubMed ID: 9626349
[TBL] [Abstract][Full Text] [Related]
18. Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma: differences between in vitro and in vivo expression.
Baker JK; Elshaw SR; Mathewman GE; Nichols CE; Murray AK; Parsons MA; Rennie IG; Sisley K
Melanoma Res; 2001 Jun; 11(3):265-73. PubMed ID: 11468515
[TBL] [Abstract][Full Text] [Related]
19. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
Rougier JP; Guia S; Hagège J; Nguyen G; Ronco PM
Kidney Int; 1998 Jul; 54(1):87-98. PubMed ID: 9648067
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
